Publication | Open Access
Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial.
26
Citations
22
References
2022
Year
Curcumin has an efficacy in improving overall remission and decreasing NF-κB, VEGF, TNF-α, and IL-6 levels in myeloma patients<b>.</b>
| Year | Citations | |
|---|---|---|
Page 1
Page 1